Atossa Genetics (ATOS) Misses Q2 EPS by 1c

Atossa Genetics (NASDAQ: ATOS) reported Q2 EPS of ($0.07), $0.01 worse than the analyst estimate of ($0.06).

For earnings history and earnings-related data on Atossa Genetics (ATOS) click here.

You May Also Be Interested In

• Cerebras CEO says investors misunderstood margin guidance
• FDA: approves Pfizer's palbociclib (ibrance) with trastuzumab for HR-positive, her2-positive metastatic breast cancer
• Airbus to inspect wings on some A380 aircraft after cracks found